Shortage of anxiety drug creates alarm among patients, doctors

Shortage of anxiety drug creates alarm among patients, doctors

(HealthDay)—A shortage of the anti-anxiety drug buspirone in the United States has patients and doctors concerned.

Buspirone is among one of the for which prices have fallen so low that many manufacturers claim they cannot make a profit on them. Not knowing when the normal supply will resume, physicians are finding it challenging to manage patients, The New York Times reported.

About 20 percent of people in the United States had an anxiety disorder in the past year, according to the National Institute of Mental Health. Relatively few of those patients use buspirone, but it is considered a much safer drug than benzodiazepine anti-anxiety drugs like Valium and Xanax, The Times reported.

Buspirone is not addictive, has few side effects, and does not cause sexual dysfunction. It can also be used to augment antidepressants and to help reduce sexual dysfunction caused by antidepressants. There is no equivalent medication that works the same way as buspirone.

Explore further

Buspirone improves symptoms in functional dyspepsia

More information: The New York Times Article

Copyright © 2019 HealthDay. All rights reserved.

Citation: Shortage of anxiety drug creates alarm among patients, doctors (2019, February 4) retrieved 22 September 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Feb 05, 2019
I can't see any evidence that this drug is in short supply outside the USA. As it is cheap, effective and non-addictive I suspect that the unregulated US Pharmaceutical industry has manufactured a shortage so that they can sell more expensive drugs that take longer to work and engender dependence.

The USA respects profitable behaviour over ethical behaviour, particularly under the current administration.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more